AmerisourceBergen Senior Vice President Chooses to Leave Company for Personal Reasons
Effective immediately, AmerisourceBergen Chief Operating Officer, Kurt J. Hilzinger, will assume Mr. Martini's responsibilities in addition to his current duties. To ensure a smooth transition, Mr. Martini is scheduled to leave the Company at the end of September 2002. Afterward, he will remain available in a consulting role.
Commenting on Mr. Martini's departure, R. David Yost, AmerisourceBergen President and Chief Executive Officer said, "Brent's contributions to AmerisourceBergen have been widespread. He has been instrumental in designing and implementing our current organization structure, playing an integral role in the completion of the merger. He provided excellent leadership in the critical months immediately following the close of the transaction, and helped shape the direction and the momentum of our new company. His energetic and enthusiastic support of me and the total AmerisourceBergen management team is greatly appreciated."
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternate care and mail order facilities, independent community pharmacies, and regional chain pharmacies.
The Company is also a leader in the institutional pharmacy marketplace. With more than $39 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers.
This press release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements herein include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.
The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its most recent 10-Q, its Annual Report on Form 10-K for fiscal 2001, and AmeriSource's and Bergen's joint proxy statement-prospectus dated August 1, 2001.
AmerisourceBergen, AmeriSource and Bergen Brunswig are under no obligation to (and expressly disclaim any such obligation to) update or alter their forward-looking statements whether as a result of new information, future events or otherwise.
(c) Copyright 2002 AmerisourceBergen Corporation.
CONTACT: AmerisourceBergen Corporation, Valley Forge Michael N. Kilpatric, 610/727-7118 firstname.lastname@example.org
(c) 2002 Business Wire. All reproduction, other than for an individual user`s reference, is prohibited without prior written permission.